GCBLX | RLBEX | GCBLX / RLBEX | |
Total Expense Ratio | 1.46 | 0.59 | 247% |
Annual Report Gross Expense Ratio | 1.46 | 0.59 | 247% |
Fund Existence | 33 years | 23 years | - |
Gain YTD | 6.106 | 10.001 | 61% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 384M | 255B | 0% |
Annual Yield % from dividends | 0.48 | 1.81 | 27% |
Returns for 1 year | -1.53 | 7.23 | -21% |
Returns for 3 years | 12.72 | 34.20 | 37% |
Returns for 5 years | 13.71 | 37.05 | 37% |
Returns for 10 years | 55.24 | 74.35 | 74% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BMEZ | 14.30 | 0.12 | +0.85% |
BlackRock Health Sciences Term Trust | |||
DRUP | 62.17 | 0.08 | +0.13% |
GraniteShares Nasdaq Sel Disruptors ETF | |||
SCCR | 25.67 | 0.02 | +0.08% |
Schwab® Core Bond ETF | |||
QMID | 27.93 | N/A | N/A |
WisdomTree U.S. Mid Cap Quality Gr | |||
UEVM | 55.03 | -0.08 | -0.14% |
VictoryShares Emerging Mkts Val MomtETF |